Drug Chatter -- Tracking biopharma stock chatter

Profile for GTx, Inc. (GTXI)

« Back to company index

GTXI Chatter Timeline

Stock Ticker for GTXI

Most Active Tweeters for GTXI

UserTweets
@biostockinfo 6
@danrocks4 3
@1MinuteStock 3
@Allstocknews 3
@stockboardinc 3

Recent Tweets for GTXI

stockboardinc @stockboardinc
$GTXI GTx Announces Webcast of Corporate Presentation at the 2017 Cantor Fitzgerald Global Healthcare Conf... - https://t.co/upaxohh5E6
September 25th 2017, 5:09pm
Allstocknews @Allstocknews
$GTXI GTx Announces Webcast of Corporate Presentation at the 2017 Cantor Fitzgerald Global Healthcare Confere From our Stock News Alerts App
September 25th 2017, 5:09pm
newswithvalue @newswithvalue
$GTXI: GTx Announces Webcast of Corporate Presentation at the 2017 …: https://t.co/hqzrpg1Llo
September 25th 2017, 5:09pm
danrocks4 @danrocks4
GTXI is number 51 for the largest percentage gain out of 100 stocks. $GTXI GTX Inc is up +14.30% in the last 5 https://t.co/NnhIedwrjn
September 25th 2017, 10:09am
PolgarStocks @PolgarStocks
stockcharts: GTXI 8.76 Updated: 09-24-2017 $GTXI Last Trade: 9/22/2017 3:56:00 PM Last 8.76   -  Open 8.02 https://t.co/RnCUXNTfhc
September 24th 2017, 5:09am
biostockinfo @biostockinfo
$gtxi needs volume; yesterday close $8.74
September 22nd 2017, 1:09am
biostockinfo @biostockinfo
RT @stockboardinc: $GTXI GTx to Host Key Opinion Leader Luncheon on the Topic of Stress Urinary Incontinence on September 28t... - https://…
September 22nd 2017, 1:09am
stockboardinc @stockboardinc
$GTXI GTx to Host Key Opinion Leader Luncheon on the Topic of Stress Urinary Incontinence on September 28t... - https://t.co/H5xKW16shU
September 21st 2017, 4:09pm
Allstocknews @Allstocknews
$GTXI GTx to Host Key Opinion Leader Luncheon on the Topic of Stress Urinary Incontinence on September 28th i From our Stock News Alerts App
September 21st 2017, 4:09pm
StockNewsWires @StockNewsWires
$GTXI: GTx to Host Key Opinion Leader Luncheon on the Topic of Stress …: https://t.co/twVwAyrXNx
September 21st 2017, 4:09pm
ZolmaxNews @ZolmaxNews
GTx $GTXI and Its Rivals Head to Head Survey https://t.co/WHZe9lHGWf
September 21st 2017, 1:09am
IRAMarketReport @IRAMarketReport
GTx $GTXI Receives News Sentiment Rating of 0.24 https://t.co/dpAcVFrnO6
September 19th 2017, 11:09am
chaffeybreeze @chaffeybreeze
GTx $GTXI Receives News Sentiment Rating of 0.24 https://t.co/4FysA0syIF
September 19th 2017, 11:09am
MaisaCorp @MaisaCorp
$GTXI positive top-line phase 2 trial results on its drug enobosarm to reduce stress urinary incontinence in women.
September 13th 2017, 3:09pm
realmaciej @realmaciej
RT @odibro: $GTXI: Positive Results from Enobosarm Phase 2 POC Clinical Trial in Women with Stress Urinary Incontinence https://t.co/ts4IK…
September 13th 2017, 12:09pm
biostockinfo @biostockinfo
$gtxi sell the news?
September 13th 2017, 12:09pm
pharma_sector @pharma_sector
#GTx GTX Corp Announces Positive Results From Enobosarm Phase II Proof-Of-Concept Clinical ... Read more: https://t.co/oymcg7NX8J $GTXI
September 13th 2017, 12:09pm
biotech_sector @biotech_sector
#GTx GTX Corp Announces Positive Results From Enobosarm Phase II Proof-Of-Concept Clinical ... Read more: https://t.co/zcUwgucJC0 $GTXI
September 13th 2017, 12:09pm
pharma_sector @pharma_sector
#GTx Announces Positive Results from Enobosarm Phase 2 Proof-of-Concept Clinical Trial in W... Read more: https://t.co/uvia097noB $GTXI
September 13th 2017, 12:09pm
biotech_sector @biotech_sector
#GTx Announces Positive Results from Enobosarm Phase 2 Proof-of-Concept Clinical Trial in W... Read more: https://t.co/MXuIfNNLNn $GTXI
September 13th 2017, 12:09pm
TheMarketsDaily @TheMarketsDaily
GTx $GTXI Given Coverage Optimism Score of 0.25 https://t.co/buh0u89X8A
September 13th 2017, 11:09am
danrocks4 @danrocks4
GTXI is number 18 for the largest percentage gain out of 100 stocks. $GTXI GTX Inc is up +33.63% in the last 5 https://t.co/ToFtowhmTx
September 13th 2017, 10:09am
Jim5011 @Jim5011
GTXI Gapped up +0.52 $GTXI Last Price 9.35 Day High 9.45 Day Low 9.08 Change +0.71 Volume 50,585 Today 25 stoc https://t.co/KmjT7lli2C
September 13th 2017, 9:09am
StockNewsNow @StockNewsNow
$GTXI GTx Announces Positive Results from Enobosarm Phase 2 Proof-of-Concept Clinical Trial in Women with Stress... https://t.co/E0ZCyXd8T0
September 13th 2017, 9:09am
MarketChmln @MarketChmln
$GTXI stock increases 10.6% in premarket, company press release at 7:00 AM https://t.co/iQ6nh0bcLn
September 13th 2017, 9:09am
StocksThatGo @StocksThatGo
NEWS $GTXI GTx Announces Positive Results from Enobosarm Phase 2 Proof-of-Concept Clinical Trial in Women with Stress Urinary Incontinence
September 13th 2017, 9:09am
SurgeTraders @SurgeTraders
$GTXI support is 9.20. Breakout over 9.6 and 10. $BVXV support is 7.8. Breakout over 8.20 and 8.6.
September 13th 2017, 9:09am
BallOnWallSt66 @BallOnWallSt66
I highly recommend everyone check this out for discovering good stocks to trade https://t.co/HqB5rJJ86A $GTXI $GPRO… https://t.co/rUdNWBfLiP
September 13th 2017, 9:09am
Briefingcom @Briefingcom
$GTXI: GTX announces top-line results 'demonstrating that a daily dose of enobosarm 3 mg substantially improved... https://t.co/ehE80IKCwj
September 13th 2017, 9:09am
ITRADEVOL @ITRADEVOL
$GTXI Latest Press Releases -- September 13, 2017 -- https://t.co/pIBDkQQpLJ
September 13th 2017, 8:09am
Hypocrites_Oath @Hypocrites_Oath
RT @OpenOutcrier: $GTXI (+11.0% pre) GTx Reports Positive Results from Enobosarm Ph 2 Proof-of-Concept Trial in Women with SUI - SI https:…
September 13th 2017, 8:09am
OpenOutcrier @OpenOutcrier
$GTXI (+11.0% pre) GTx Reports Positive Results from Enobosarm Ph 2 Proof-of-Concept Trial in Women with SUI - SI https://t.co/uSfasJsa3Y
September 13th 2017, 8:09am
biostockinfo @biostockinfo
RT @BioStocks: $GTXI Announces Positive Results From Enobosarm Phase 2 Trial in Women With Stress Urinary Incontinence
September 13th 2017, 8:09am
kreatlvekeni @kreatlvekeni
RT @ITRADEVOL: A table for both the upcoming quarterly earnings releases and historical releases for $gtxi https://t.co/PK28devMqL
September 13th 2017, 8:09am
ITRADEVOL @ITRADEVOL
A table for both the upcoming quarterly earnings releases and historical releases for $gtxi https://t.co/PK28devMqL
September 13th 2017, 8:09am
TheUnicornBay @TheUnicornBay
Recommendation #HOLD for $GTXI with UB rating - 2.46 out of 5. https://t.co/tMBzrN3fZG
September 13th 2017, 7:09am
confcalltran @confcalltran
GTx: Positive Results From Enobosarm Phase 2 Proof-Of-Concept Clinical Trial In Women With Stre https://t.co/aBBcOZTVNW $GTXI
September 13th 2017, 7:09am
Onellymr @Onellymr
$GTXI GTx Announces Positive Results from Enobosarm Phase 2 Proof-of-Concept Clinical Trial in Women wi... https://t.co/RSnUqiwXM1
September 13th 2017, 7:09am
odibro @odibro
$GTXI: Positive Results from Enobosarm Phase 2 POC Clinical Trial in Women with Stress Urinary Incontinence https://t.co/ts4IKWNcve
September 13th 2017, 7:09am
efinancialpub @efinancialpub
RT @Allstocknews: $GTXI GTx Announces Positive Results from Enobosarm Phase 2 Proof-of-Concept Clinical Trial in Women with Str From our St…
September 13th 2017, 7:09am
stockboardinc @stockboardinc
$GTXI GTx Announces Positive Results from Enobosarm Phase 2 Proof-of-Concept Clinical Trial in Women with ... - https://t.co/qzTNI4vSUt
September 13th 2017, 7:09am
stocknewsdotcom @stocknewsdotcom
$GTXI Announces top-line results 'demonstrating that a daily dose of enobosarm 3 mg substantially improved stress… https://t.co/eYnVFL93b2
September 13th 2017, 7:09am
Allstocknews @Allstocknews
$GTXI GTx Announces Positive Results from Enobosarm Phase 2 Proof-of-Concept Clinical Trial in Women with Str From our Stock News Alerts App
September 13th 2017, 7:09am
BioStocks @BioStocks
$GTXI Announces Positive Results From Enobosarm Phase 2 Trial in Women With Stress Urinary Incontinence
September 13th 2017, 7:09am
1MinuteStock @1MinuteStock
Wondering about risks of $GTXI? The 63-day volatility is 30.96% https://t.co/m7kcfnV23f
September 13th 2017, 2:09am
1MinuteStock @1MinuteStock
Not sure what to do with $GTXI? Explore our #fundamental pros and cons. https://t.co/B6K4x1Vzga
September 12th 2017, 7:09pm
1MinuteStock @1MinuteStock
We calculated 63-day Expected Return of $GTXI for you: 39.67% https://t.co/h6j5M1wMUl
September 12th 2017, 2:09pm
IncredibleTrade @IncredibleTrade
$CODX targeting for new highs just like $GTXI and other swing plays that I posted earlier .. https://t.co/BK6e7xU0r8
September 12th 2017, 1:09pm
biostockinfo @biostockinfo
$gtxi another green day
September 12th 2017, 1:09pm
tickerfinder1 @tickerfinder1
$GTXI Watching for a longer term opportunity. #investment #investor #stocks #stockmarket $trader https://t.co/Ws8COmfK0Q
September 12th 2017, 12:09pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.